Stockreport

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

BioNTech SE - American Depositary Shares  (BNTX) 
PDF Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next mile [Read more]